Cereno Scientific looks ahead with confidence – can look back on a successful first half of 2019

15 July, 2019

The first half of 2019 has been characterised by important milestones for Cereno Scientific, from an oversubscribed issue and significant reinforcements to the organisation to acquisition of a new substance and an application to initiate phase II for their primary candidate, CS1. Together with CEO Sten R. Sörensen, BioStock summarises the past 6 months and looks ahead at new challenges and big events.

To read the full article on BioStock, click here.